Open calls · Research grant · Medicine
Immune Tolerance Network (UM1 Clinical Trial Required)
National Institutes of Health · Allergy and Infectious Diseases Research · RFA-AI-28-005
Deadlines
- 29 Jan 2027 Deadline in 79 days
Who can apply
- Where the work is done
- United States
- Who applies
- An organisation
Money
- Total budget
- $27M
- Expected awards
- 1
About the call
The purpose of this notice of funding opportunity (NOFO) is to support applications to continue the Immune Tolerance Network (ITN). The primary objective of the Network is to develop tolerogenic therapies for immune-mediated disorders. The three main clinical areas of work are: 1) Allergic diseases and asthma; 2) Autoimmune diseases; and 3) Immune-mediated consequences of transplantation. The core functions of the ITN include designing, conducting, and sharing the results of clinical trials and performing integrated mechanistic studies.
Text from the funder (US federal government, public domain).
Conditions in full
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
We sort calls into fields, career stages and countries automatically. Always check the conditions on the funder’s page before you apply.
Discussion
Applying too? Looking for partners? Ask here.